Emran Askari

602 total citations
51 papers, 402 citations indexed

About

Emran Askari is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Emran Askari has authored 51 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Infectious Diseases. Recurrent topics in Emran Askari's work include Antimicrobial Resistance in Staphylococcus (11 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Prostate Cancer Treatment and Research (9 papers). Emran Askari is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (11 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Prostate Cancer Treatment and Research (9 papers). Emran Askari collaborates with scholars based in Iran, United States and Switzerland. Emran Askari's co-authors include Rahil Mashhadi, Mohammad Reza Pourmand, Kamran Aryana, Reyhaneh Manafi‐Farid, Isaac Shiri, Christian Pirich, Habib Zaidi, Mohsen Beheshti, Maziar Khateri and Ahmadreza Zarifian and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Radiology and Microbial Pathogenesis.

In The Last Decade

Emran Askari

36 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emran Askari Iran 12 218 182 138 79 64 51 402
Huifen Ye China 11 172 0.8× 210 1.2× 108 0.8× 57 0.7× 18 0.3× 26 510
Martin Vondracek Sweden 12 321 1.5× 260 1.4× 61 0.4× 35 0.4× 32 0.5× 19 691
Sanjay Gautam Australia 10 234 1.1× 131 0.7× 47 0.3× 11 0.1× 49 0.8× 28 459
Olivier Del Corpo Canada 11 323 1.5× 86 0.5× 85 0.6× 13 0.2× 35 0.5× 20 488
Xiaojiong Jia China 16 89 0.4× 118 0.6× 70 0.5× 10 0.1× 55 0.9× 26 531
Yasutaka Nakamura Japan 12 85 0.4× 87 0.5× 38 0.3× 12 0.2× 64 1.0× 64 385
Itaru Furuta Japan 12 94 0.4× 88 0.5× 37 0.3× 22 0.3× 20 0.3× 42 337
Akhil Garg Canada 7 128 0.6× 53 0.3× 80 0.6× 17 0.2× 9 0.1× 10 246
Nicholas Britt United States 12 298 1.4× 157 0.9× 185 1.3× 4 0.1× 66 1.0× 30 591
Xinfeng Xu China 16 105 0.5× 155 0.9× 8 0.1× 64 0.8× 207 3.2× 40 584

Countries citing papers authored by Emran Askari

Since Specialization
Citations

This map shows the geographic impact of Emran Askari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emran Askari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emran Askari more than expected).

Fields of papers citing papers by Emran Askari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emran Askari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emran Askari. The network helps show where Emran Askari may publish in the future.

Co-authorship network of co-authors of Emran Askari

This figure shows the co-authorship network connecting the top 25 collaborators of Emran Askari. A scholar is included among the top collaborators of Emran Askari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emran Askari. Emran Askari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Askari, Emran, et al.. (2025). 99mTc-PSMA Scintigraphy in Splenic Hemangioma. Clinical Nuclear Medicine. 51(1). e68–e69.
2.
3.
Askari, Emran, et al.. (2024). [68 Ga]Ga-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression. European Journal of Radiology. 180. 111694–111694. 1 indexed citations
4.
Meibodi, Naser Tayyebi, et al.. (2024). Cutaneous and Subcutaneous Prostate-Specific Membrane Antigen–Avid Lesions. Clinical Nuclear Medicine. 50(3). e164–e165. 2 indexed citations
5.
Askari, Emran, et al.. (2024). Quadruplet Therapy in De Novo High-Volume Mixed Neuroendocrine Prostate Cancer Using 177Lu-PSMA. Clinical Nuclear Medicine. 49(3). e120–e122. 1 indexed citations
6.
Zakavi, Seyed Rasoul, et al.. (2024). Effects of radioactive iodine therapy on female sex hormones and menstrual cycle in patients with differentiated thyroid carcinoma. Clinical and Translational Imaging. 13(1). 65–71.
7.
Hajianfar, Ghasem, Abdollah Saberi, Seyed Rasoul Zakavi, et al.. (2024). Stable Diffusion Model-Based Scintigraphy Image Synthesis: Data Augmentation Toward Enhanced Multiclass Thyroid Diagnosis. 1–6.
8.
Mahdavi, Seied Rabi, Mohsen Chamanara, Reza Mosaed, et al.. (2023). Bipolar Androgen Therapy: When Excess Fuel Extinguishes the Fire. Biomedicines. 11(7). 2084–2084. 3 indexed citations
9.
10.
Askari, Emran, et al.. (2022). Could Fibroblast Activation Protein (FAP)‐Specific Radioligands Be Considered as Pan‐Tumor Agents?. Contrast Media & Molecular Imaging. 2022(1). 3948873–3948873. 18 indexed citations
11.
Askari, Emran, et al.. (2020). Parotid metastasis as the first presentation of papillary thyroid carcinoma. 28(2). 42–45. 1 indexed citations
12.
Askari, Emran, et al.. (2020). 177 Lu-EDTMP for Metastatic Bone Pain Palliation: A Systematic Review and Meta-Analysis. Cancer Biotherapy and Radiopharmaceuticals. 36(5). 383–390. 5 indexed citations
13.
Zarifian, Ahmadreza, et al.. (2015). Inducible Clindamycin Resistant Staphylococcus aureus in Iran: A Systematic Review and Meta-Analysis. SHILAP Revista de lepidopterología. 3 indexed citations
14.
Askari, Emran, et al.. (2015). Study on Bacteria Associated with White Coats of Healthcare Workers in Two Tertiary Hospitals, Mashhad, Iran. SHILAP Revista de lepidopterología. 3 indexed citations
15.
Pourmand, Mohammad Reza, et al.. (2015). Frequency and Antimicrobial Resistance Patterns of Methicillin-Resistant Staphylococcus aureus in Tehran. SHILAP Revista de lepidopterología. 2 indexed citations
16.
Askari, Emran, et al.. (2013). High-Level Vancomycin-Resistant Staphylococcus aureus (VRSA) in Iran: A Systematic Review. SHILAP Revista de lepidopterología. 15 indexed citations
17.
Pourmand, Mohammad Reza, et al.. (2013). Solid Phase Chemical Synthesis and Structure - Activity Study of Brevinin - 2R and Analogues as Antimicrobial Peptides. 2(3). 41–46. 5 indexed citations
18.
Ashrafian, Fatemeh, et al.. (2013). The Frequency of Extended Spectrum Beta Lactamase (ESBL) in Escherichia coli and Klebsiella pneumoniae: A Report from Mashhad, Iran. SHILAP Revista de lepidopterología. 2. 12–19. 15 indexed citations
19.
Askari, Emran, et al.. (2012). Inducible clindamycin resistance in Staphylococcus aureus isolates recovered from Mashhad, Iran. SHILAP Revista de lepidopterología. 25 indexed citations
20.
Javanbakht, Arash, et al.. (2012). The incidence of cross infections in Imam Reza hospital, Mashhad, Iran. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huifen Ye Breakdown of academic impact, for papers by Martin Vondracek Breakdown of academic impact, for papers by Sanjay Gautam Breakdown of academic impact, for papers by Olivier Del Corpo Breakdown of academic impact, for papers by Xiaojiong Jia Breakdown of academic impact, for papers by Yasutaka Nakamura Breakdown of academic impact, for papers by Itaru Furuta Breakdown of academic impact, for papers by Akhil Garg Breakdown of academic impact, for papers by Nicholas Britt Breakdown of academic impact, for papers by Xinfeng Xu
Rankless by CCL
2026